February 11, 2012
| Bio-IT World > Unix for the Rest of Us


Unix for the Rest of Us


The BioTeam's Bill Van Etten explains why Apple Computer is acquiring a new sheen in the life sciences.


March 10, 2003 | "One reason is certainly ease of use. The other is having desktop productivity tools that are manageable by a person with Unix [operating] underneath. Right now the options are Windows without Unix or Linux without desktop productivity tools. So, [Unix-based] Mac OS 10 is my desktop [operating system] of choice. I have no use for an operating system that is not Unix for my research. I mean, Windows is completely useless.

"If you took the hundreds of bioinformatics applications that are available, could you run them all on Windows? If you want to put Windows and Mac OS 10 on top of Linux, you can do that. But to be able to run Microsoft Office side by side with BLAST in a terminal window without having to do weird emulation, that's a big deal. To be able to take the output from a Unix command line and bring it into Microsoft Word or the other way around, that's very useful.

"I think Apple likes us because we have credibility with Linux and Solaris, and they get [feedback] about their shortcomings and the benefits. Also, we've been working with them for a year or more, helping them understand the space and where they fit in the market ... In situations where ease of use is required, they win hands down in terms of providing high-throughput computing. So if I were a small laboratory where I had to build and support my own large-scale computing environment, like Texas A&M, I would say that Apple Xserve fits in very well. Also, any situations where a large fraction of the compute power goes to these vectorized applications like BLAST. You can buy 10 times fewer machines to get the same computing done."


Back to The BioTeam: Riders of the Storm 





White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  





For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .